Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucolipin-2 (TRPML2) is a non-selective cation channel belonging to the mucolipin subfamily of the transient receptor potential (TRP) superfamily. It is primarily localized to the membranes of recycling endosomes and lysosomes, with high expression levels found in lymphoid and myeloid cells such as macrophages and B lymphocytes. TRPML2 plays a critical role in the innate immune response by regulating the trafficking and secretion of chemokines, most notably CCL2, and is upregulated following Toll-like receptor (TLR) activation. In the context of infectious diseases, TRPML2 has been shown to influence the endocytic trafficking of enveloped viruses, including Zika, Influenza A, and Yellow Fever, which can paradoxically enhance viral entry or facilitate clearance depending on the cellular context. Furthermore, TRPML2 is implicated in cancer progression, particularly in glioblastoma, where its high expression supports tumor cell viability and proliferation. Pharmacological modulation of TRPML2 using selective small-molecule agonists like ML2-SA1 is currently being explored as a strategy to enhance immune defense and correct endolysosomal trafficking defects.
Agonism of the TRPML2 cation channel promotes the release of calcium and sodium from endolysosomal compartments into the cytosol, which triggers vesicular trafficking, enhances the secretion of chemokines such as CCL2, and modulates immune cell activation and viral processing.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucolipin-2 (TRPML2) (TRPML2).